Diamonds and Dogs
Big blue led the Dow higher on Trump's first day on the job. IBM rose 2% following better than expected earnings last night and raised guidance for the first quarter. The company said they exited 2016 in a stronger position with their fastest growing divisions contributing more and more revenue. The strategic imperative divisions (cloud, analytics, mobility, and security) rose 16% year over year delivering nearly $32 billion in revenue or 40% of total sales. The analyst at Stifel upgraded IBM with a $192 price target.
Another bad day for Bristol Myers (BMY). The stock dropped 11% back to the October 52 week lows after the company announced they will not pursue accelerated regulatory pathway for combination of Opdivo plus Yervoy in first-line lung cancer in the US based on review of data available at this time. Approval of the drug would've added billions to the company's annual revenue. Rival, Merck rose 3% on the Bristol news.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.